197 related articles for article (PubMed ID: 20348446)
21. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
22. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.
Sowden M; Hamm JK; Smith HC
J Biol Chem; 1996 Feb; 271(6):3011-7. PubMed ID: 8621694
[TBL] [Abstract][Full Text] [Related]
24. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
[TBL] [Abstract][Full Text] [Related]
25. APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.
Dance GS; Sowden MP; Yang Y; Smith HC
Nucleic Acids Res; 2000 Jan; 28(2):424-9. PubMed ID: 10606639
[TBL] [Abstract][Full Text] [Related]
26. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
Lau PP; Chan L
J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
Chen Z; Eggerman TL; Patterson AP
Biochem J; 2001 Aug; 357(Pt 3):661-72. PubMed ID: 11463337
[TBL] [Abstract][Full Text] [Related]
28. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
29. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
Lau PP; Zhu HJ; Nakamuta M; Chan L
J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
[TBL] [Abstract][Full Text] [Related]
30. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
Chester A; Scott J; Anant S; Navaratnam N
Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
[TBL] [Abstract][Full Text] [Related]
31. Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography.
Yang Y; Yang Y; Kovalski K; Smith HC
J Biol Chem; 1997 Oct; 272(44):27700-6. PubMed ID: 9346911
[TBL] [Abstract][Full Text] [Related]
32. Analysis of protein complexes assembled on apolipoprotein B mRNA for mooring sequence-dependent RNA editing.
Smith HC
Methods; 1998 May; 15(1):27-39. PubMed ID: 9614650
[TBL] [Abstract][Full Text] [Related]
33. Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.
Blanc V; Henderson JO; Newberry EP; Kennedy S; Luo J; Davidson NO
Mol Cell Biol; 2005 Aug; 25(16):7260-9. PubMed ID: 16055734
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction.
Yang Y; Ballatori N; Smith HC
Mol Pharmacol; 2002 Feb; 61(2):269-76. PubMed ID: 11809850
[TBL] [Abstract][Full Text] [Related]
35. Apobec-1 and apolipoprotein B mRNA editing.
Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
[TBL] [Abstract][Full Text] [Related]
36. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
[TBL] [Abstract][Full Text] [Related]
37. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.
Lellek H; Kirsten R; Diehl I; Apostel F; Buck F; Greeve J
J Biol Chem; 2000 Jun; 275(26):19848-56. PubMed ID: 10781591
[TBL] [Abstract][Full Text] [Related]
38. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.
von Wronski MA; Hirano KI; Cagen LM; Wilcox HG; Raghow R; Thorngate FE; Heimberg M; Davidson NO; Elam MB
Metabolism; 1998 Jul; 47(7):869-73. PubMed ID: 9667237
[TBL] [Abstract][Full Text] [Related]
39. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein.
Anant S; MacGinnitie AJ; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14762-7. PubMed ID: 7782342
[TBL] [Abstract][Full Text] [Related]
40. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
Hersberger M; Innerarity TL
J Biol Chem; 1998 Apr; 273(16):9435-42. PubMed ID: 9545269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
